Mrv1909 02282022412D 11 11 0 0 0 0 999 V2000 1.0717 -0.8250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.7863 -0.4126 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 0.3572 -0.4126 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 -0.3572 -0.8250 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 -0.3572 -1.6501 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -1.0717 -0.4126 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 -1.7863 -0.8250 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -1.0717 0.4124 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.3572 0.8250 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 0.3572 0.4124 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -0.3572 1.6501 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 1 2 1 0 0 0 0 3 1 1 6 0 0 0 3 4 1 0 0 0 0 4 5 1 6 0 0 0 4 6 1 0 0 0 0 6 7 1 6 0 0 0 6 8 1 0 0 0 0 9 8 1 0 0 0 0 10 9 1 0 0 0 0 3 10 1 0 0 0 0 9 11 1 1 0 0 0 M END > DB04382 > drugbank > OC[C@H]1O[C@H](O)C[C@@H](O)[C@H]1O > InChI=1S/C6H12O5/c7-2-4-6(10)3(8)1-5(9)11-4/h3-10H,1-2H2/t3-,4-,5+,6-/m1/s1 > PMMURAAUARKVCB-ARQDHWQXSA-N > C6H12O5 > 164.1565 > 164.068473494 > 5 > 23 > -5.925585883685738e-06 > 15.289424992165753 > 1 > 4 > 0 > 0 > (2S,4R,5R,6R)-6-(hydroxymethyl)oxane-2,4,5-triol > -2.54 > -2.031901155 > 0.78 > 0 > 0 > 1 > 0 > 13.168346097486781 > 12.294304229799055 > -2.9809323333536977 > 90.15 > 34.412699999999994 > 1 > 1 > 9.84e+02 g/l > L-saccharopine > 0 > DB04382 > EXPT00111 > experimental > 2-Deoxy-alpha-D-galactopyranose > 2-Deoxy-alpha-D-lyxo-hexopyranose; 2-deoxy-beta-D-galactose; 2-Deoxy-α-D-lyxo-hexopyranose $$$$